NCT03033238

Brief Summary

The purpose of this study is to investigate opportunities for prevention and treatment of knee osteoarthritis (OA) by evaluating potentially modifiable risk factors for disease and poor pain and physical function outcomes especially among those with early or mild knee symptoms. The goal of the study is to find novel strategies to prevent disease at an early stage and to limit the impact of disease once it has occurred.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4,185

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2003

Longer than P75 for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2003

Completed
13.9 years until next milestone

First Submitted

Initial submission to the registry

December 1, 2016

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 26, 2017

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

February 16, 2021

Status Verified

February 1, 2021

Enrollment Period

17.9 years

First QC Date

December 1, 2016

Last Update Submit

February 12, 2021

Conditions

Outcome Measures

Primary Outcomes (3)

  • Worsening knee pain

    Worsening knee pain defined as reaching minimally clinically important difference (MCID) for worsening on the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain questionnaire

    Change from baseline (144-month) at ≥2 follow-up contacts (152-, 160-, 168-month follow-up contacts)

  • Incident cartilage loss on MRI

    Incidence of cartilage loss on MRI extending to the bone

    Change from baseline (144-month) at 168-month follow-up contact

  • Function loss

    Defined as minimally clinically important difference (MCID) for worsening on the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) function questionnaire

    Change from baseline (144-month) at ≥2 follow-up contacts (152-, 160-, 168-month follow-up contacts)

Secondary Outcomes (5)

  • Onset of constant knee pain

    Change from baseline (144-month) at ≥2 follow-up contacts (152-, 160-, 168-month follow-up contacts)

  • Worsening on MRI

    Change from baseline (144-month) at 168-month follow-up contact

  • Worsening on X-ray

    Change from baseline (144-month) at 168-month follow-up contact

  • New onset knee buckling

    Change from baseline (144-month) at ≥1 follow-up contact (152-, 160-, 168-month follow-up contacts)

  • New repeated falls

    Change from baseline (144-month) at ≥1 follow-up contact (152-, 160-, 168-month follow-up contacts)

Study Arms (1)

Early or mild knee symptoms

Existing Cohort study participants (3,026) were enrolled in 2003-2005, Surviving participants without endstage knee osteoarthritis will be asked to participate in the 144-, 152-, 160- and 168-month follow-up contacts \[2,660 were enrolled\]. New Cohort study participants (1,500) will be recruited and enrolled in 2016-2018 \[1,525 were enrolled\].

Eligibility Criteria

Age45 Years - 79 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The purpose of this study is to investigate opportunities for prevention and treatment of knee osteoarthritis by evaluating potentially modifiable risk factors for disease and poor pain and physical function outcomes especially among those with early or mild knee symptoms. The goal of the study is to find novel strategies to prevent disease at an early stage and to limit the impact of disease once it has occurred.

You may qualify if:

  • Age 45 to 69 Years (Adult, Senior)
  • Males and Females
  • Healthy Volunteers
  • Community-based Sample

You may not qualify if:

  • Rheumatoid or inflammatory arthritis (based on self-report and use of medications specific to these conditions)
  • Serious health condition e.g., end-stage renal disease, etc. that would likely limit follow-up to less than 2-3 years
  • Plan to relocate out of geographic region in next 3 years
  • Not able to walk without the aid of a person or assistive device
  • Knee joint replacement surgery in either knee
  • Neither knee fits in the MRI knee coil (determined during Screening Visit).
  • Not competent to give informed consent
  • Advanced structural tibiofemoral or patellofemoral knee OA disease (KL grade 3 or 4) in either knee (Determined by Knee X-ray Screening)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

University of Alabama at Birmingham

Birmingham, Alabama, 35294, United States

Location

University of Iowa

Iowa City, Iowa, 52240, United States

Location

Boston University School of Medicine

Boston, Massachusetts, 02118, United States

Location

Related Publications (1)

  • Rabe KG, Stockman TJ, Kern AM, Wirth W, Eckstein F, Sharma L, Lynch JA, Nevitt MC, Anderson DD, Segal NA. Longitudinal Relationship Between Tibiofemoral Contact Stress at Baseline and Worsening of Knee Pain Over 84 Months in the Multicenter Osteoarthritis Study. Am J Phys Med Rehabil. 2022 Aug 1;101(8):726-732. doi: 10.1097/PHM.0000000000001899. Epub 2021 Oct 8.

Biospecimen

Retention: SAMPLES WITH DNA

Existing Cohort biospecimens were collected at enrollment, 30-month and 60-month follow-up. New Cohort biospecimens will be collected at 144-month which will be their enrollment visit).

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Michael Nevitt, PhD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 1, 2016

First Posted

January 26, 2017

Study Start

January 1, 2003

Primary Completion

December 1, 2020

Study Completion

December 1, 2020

Last Updated

February 16, 2021

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will share

Anonymized clinical data will be shared via The NIA Biobank (https://agingresearchbiobank.nia.nih.gov/). MOST Existing Cohort data from previous grant cycles will be available in mid 2021. For more information visit MOST Online (https://most.ucsf.edu).

Shared Documents
STUDY PROTOCOL
Access Criteria
See NIA Biobank website
More information

Locations